Brain injury markers: S100 calcium-binding protein B, neuron-specific enolase and glial fibrillary acidic protein in children with diabetic ketoacidosis

Pediatric Diabetes
Gönül ÇatlıAyhan Abacı

Abstract

To investigate serum levels of brain injury markers in diabetic ketoacidosis (DKA) and the relation of these markers with clinical and radiological findings of brain injury and laboratory results. Twenty-nine patients with DKA, 30 with type 1 diabetes mellitus (T1DM), and 35 healthy children were included. Clinical and laboratory findings, and the Glasgow Coma Scale (GCS) were recorded. In the DKA group, neuron-specific enolase (NSE), S100 calcium-binding protein B (S100B) and glial fibrillary acidic protein (GFAP) levels were measured at baseline and 6 and 12 hours after treatment. Magnetic resonance imaging was performed in the DKA group to demonstrate any brain injury. No clinical or radiological findings of brain injury were found in any of the patients with DKA. In the DKA group, S100B was significantly higher than the healthy control and T1DM groups, while GFAP and NSE levels were not different from controls and T1DM patients. No significant differences were found in GFAP, NSE and S100B levels according to severity of DKA, diabetes duration and GCS. NSE and GFAP levels do not increase in DKA patients without overt brain injury. Elevated levels of S100B, which is also synthesized from non-neuronal tissues, might arise from...Continue Reading

References

Jun 4, 1999·Stroke; a Journal of Cerebral Circulation·M T WunderlichM Herrmann
Dec 29, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·E A McIntyreR A Sherwood
Jun 24, 2004·The Journal of Trauma·Olli SavolaMatti Hillbom
Dec 8, 2004·The Journal of Trauma·Linda E PelinkaAndreas Raabe
Aug 5, 2005·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Subhankar BandyopadhyayChristine M Walsh-Kelly
Apr 25, 2006·Pediatric Diabetes·Nicole S GlaserNathan Kuppermann
May 25, 2007·Neurocritical Care·Stephen M BloomfieldJonathan Brisman
May 6, 2008·Clinical Biochemistry·Carlos-Alberto GonçalvesPatrícia Nardin
Oct 14, 2008·The Journal of Trauma·Kimberly M LumpkinsThomas Scalea
Jul 14, 2010·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Douglas D FraserUNKNOWN Canadian Critical Care Translational Biology Group
Jan 24, 2012·Neuroscience Letters·Nicole GlaserMartha O'Donnell
May 29, 2014·Pediatric Diabetes·Robert C Tasker, Carlo L Acerini
Aug 10, 2015·Brain Research·Nicole GlaserMartha O׳Donnell
Sep 1, 2015·Journal of Clinical Research in Pediatric Endocrinology·Cemil KayaMahmut Abuhandan
Nov 4, 2015·Journal of the Royal Army Medical Corps·Emma TomanT Belli
Feb 3, 2016·Journal of Clinical Research in Pediatric Endocrinology·Ashley B JessupAli S Çalıkoğlu
May 18, 2016·Neuroscience and Biobehavioral Reviews·Keisuke KawataDianne Langford
Jan 7, 2017·Journal of Child Neurology·Sherifa HamedTahra Sherief
Mar 16, 2017·World Journal of Biological Chemistry·Seelora SahuDevi Prasad Samaddar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.